- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02619175
Characteristics of Balance Control to Unexpected Loss of Balance During Standing and Walking in Post-stroke Individuals
Study Overview
Status
Conditions
Detailed Description
60 stroke subjects from the neurology rehabilitation unit at Loewenstein hospital will be randomly allocated to one of two groups: 1) perturbations based balance training 2) weight shifting and gait training without external perturbations (control).
Group 1 - Perturbations based balance training Subjects will complete a perturbation based balance training while standing and walking on the BalanceTutor (MediTouch). Perturbation level will be individually adjusted and progressed according to subject's abilities. Progression occurs by increasing perturbation level (increase distance, velocity and acceleration). At each practiced level subjects will be exposed to random right/left/forward/backward unannounced platform translations while standing and to right/left perturbations (in defined events in gait cycle) while walking. In order to examine adaptation to repeated perturbations, kinematic data will be collected in the first session.
Group 2 - Weight shifting and gait training Subjects will complete a balance training program that includes voluntary weight shifting while standing on a computerized posturography (NeuroCom) and walking on a treadmill. Weight shifting toward a target will be adjusted and progressed according to subject's abilities. Progression in difficulty level will occur by increasing the distance to target without changing the base of support. At each practiced level weight shifting will be conducted to right/left/forward/backward directions. In the gait part of the session, subjects will be asked to walk at their preferred treadmill walking speed.
Subjects in both groups will complete 10-12 training sessions, 4-5 per week for 3 weeks. Each session will last 30 minutes and will include practice in standing and walking. Subject's activities will be documented in each session in both groups. Furthermore, in each session subjects will be asked to rate their perceived level of challenge on a 0-10 scale.
Pre- and post-intervention measurements will be conducted. A follow-up measurement will be conducted 3-6 weeks post intervention.
The following measurements will be administered:
1)Compensatory balance reaction kinematic measurement:
Compensatory balance reactions will be measured using the BalanceTutor (MediTouch). The BalanceTutor is a mechatronic device consisting of a computerized treadmill with a horizontal movable platform and an operator station. Measurements will be taken in two conditions:
Standing. Subjects will be instructed to stand and will be exposed to random unexpected platform translations. The platform translations will be increased systematically and controlled. The increases in platform translation will be adjusted by the examiner to the subject's ability to recover from perturbations. Participants will be asked to respond in a "natural" manner to perturbations.
Walking. Subjects will be instructed to walk comfortably (self-paced) on the treadmill, and will be exposed to random unexpected platform translations. The platform translations will be increased systematically and controlled and will be adjusted by the examiner to the subject's ability to recover from perturbations. Compensatory balance reaction characteristics (reaction time, swing time, compensatory step time, step length etc.) will be collected through a three-dimensional motion analysis system. During examination subjects will wear a loose safety harness that will prevent a fall and yet allow the execution of balance recovery reactions.
In addition, clinical measures will be used: Berg Balance Scale, 6 minute walk test, 10 meter walk test, the Fugl-Meyer test for motor recovery after stroke and the ABC (Activities-specific Balance Confidence) scale. Normalized lesion data will be computed using the ABLE module within MEDx software (Medical Numerics).
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Raanana, Israel
- Loewenstein Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
For measurements taken while standing, post stroke subjects will meet the criteria of being able to stand independently or with supervision for at least 2 minutes.
For measurements taken while walking, post stroke subjects will meet the criteria of being able to walk for at least 10 meter with supervision/independently without walking aids.
- 3 weeks-6 months post stroke (hemorrhage/infarct)
- First stroke
- Age 25-75 years
- Able to understand research instructions
- Stable clinical/metabolic state
Exclusion Criteria:
- - A history of neurological diseases amongst peripheral neuropathy
- Significant skeletal system diseases, such as severe osteoporosis
- Uncontrolled atrial fibrillation
- Unstable ischemic heart disease
- Significant visual deficiency
- Dizziness
- Pregnancy
- Body weight above 135 kg
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Perturbation-based balance training
perturbation-based balance training while standing and walking on the BalanceTutor (MediTouch). 10-12 training sessions, 4-5 per week for 3 weeks. Each session will last 30 minutes. |
|
|
Active Comparator: Weight shifting and gait training
Balance and gait training without external perturbations. Voluntary weight shifting while standing on a computerized posturography (NeuroCom) and walking on a treadmill. 10-12 training sessions, 4-5 per week for 3 weeks. Each session will last 30 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Compensatory Step Execution Time
Time Frame: 1-5 days before the first session of intervention and 1-5 days after the last session of intervention.
|
Will be calculated as the time from platform perturbation to foot contact using a 3D motion analysis system. Step execution time in response to surface translations toward the non-paretic side. |
1-5 days before the first session of intervention and 1-5 days after the last session of intervention.
|
|
Change in Compensatory Step Velocity
Time Frame: 1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
will be calculated from step length and step swing time data, using a 3D motion analysis system. Step velocity in response to surface translations toward the non-paretic side. |
1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Berg Balance Scale Score
Time Frame: 1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
A 14-item objective measure (ordinal scale) designed to assess static balance and fall risk. Minimus score =0, Maximal score=56. Higher values represent a better outcome. |
1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
|
Change in Fall Threshold
Time Frame: 1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
The perturbation level at which the subject lost balance and fell into the safety harness.
Score on a scale (1-7).
Each unit represents the perturbation intensity where the subject was unable to recover balance and fell into harness system.
Higher values represent a better outcome.
|
1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
|
Change in Activities-specific Balance Confidence (ABC) Scale
Time Frame: 1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
A self-report measure of balance confidence in performing various activities without losing balance or experiencing a sense of unsteadiness.
Score on a scale (0-100).
Higher values represent a better outcome.
|
1-3 days before the first session of intervention and 1-3 days after the last session of intervention.
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- loe150021ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
Clinical Trials on Stroke Subjects Perturbation-Based Balance Training
-
National Yang Ming UniversityCompletedFall | Old Age; DebilityTaiwan
-
Toronto Rehabilitation InstituteCanadian Institutes of Health Research (CIHR)Recruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
University of DelawareNational Institute of General Medical Sciences (NIGMS)TerminatedStrokeUnited States
-
Cairo UniversityActive, not recruitingHemiplegic Cerebral PalsyEgypt
-
The Hong Kong Polytechnic UniversityRecruitingBrain Connectivity | Falling | Postural Stability | Community Dwelling Older Adults | Brain StructureHong Kong
-
University Health Network, TorontoCompleted
-
National Taiwan University HospitalCompletedCervical MyelopathyTaiwan
-
University of OldenburgUniversity of Ulm; University of Konstanz; Marienhospital Herne; Heidelberg University... and other collaboratorsRecruitingCognitive Impairment | Exercise | Geriatrics | Fall Prevention | PerturbationGermany
-
Lama Saad El-Din MahmoudCompleted